Oura, the maker of a health-tracking smart ring, has postponed its planned IPO on the Nasdaq due to uncertainty in the IPO market, despite strong demand and business growth. The company had launched its IPO plans on September 21, aiming to raise up to $2.2 billion by selling 50 million shares. CEO Tom Hale emphasized that the delay allows them to choose the right moment to deliver a successful IPO while continuing to focus on business opportunities ahead.
The smart ring maker Oura has postponed its IPO due to market uncertainty. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 29, 2026 17:01 WIB: out of 150 priced US tech stocks, 80 rose and 63 fell. Notable movers include AXTI at USD 75.00 with 88% buy orders and ARM at USD 288.00 with 93% buy orders.
The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...
DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...
Shurgard Self Storage, a leading European self-storage REIT, is currently trading at a significant discount to its net tangible assets (NTA) with a valuation of 0.48x NTA. It offers an attractive dividend yield of 4.5% and benefits from strong urbani...
Kiniksa Pharmaceuticals International, plc announced that its management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 16, 2026. The event will be webcast live and available for replay on the ...
Lakefront Biotherapeutics reported a net profit of €13.9 million for the first nine months of 2026, a significant turnaround from a €461.3 million loss in the same period last year. The company highlighted progress with its autoimmune drug gamgertami...
